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Structures of HIV-1 reverse transcriptase (RT) have
been reported in several forms, but only one contains
an RNA/DNA hybrid, the conformation of which has
been controversial. We have been successful in obtain-
ing three structures of HIV-1 RT complexed with a
non-nucleoside RT inhibitor (NNRTI) and an RNA/
DNA hybrid [1]. In the presence of an NNRTI, our
RNA/DNA structure differs from all prior nucleic acid
bound to RT including the previously-reported RNA/
DNA hybrid derived froom the polypurine tract. The
enzyme structure observed in our cocrystals also differs
from all previous RT-DNA complexes. As a result, the
hybrid has ready access to the ribonuclease H (RNase
H) active site. These observations collectively reinforce
previous proposals that an RT-nucleic acid complex
may be required to adopt independent structural states
competent for DNA synthesis and the other for RNA
degradation. RT mutations that confer drug resistance
but are distant from the inhibitor-binding sites map to
the unique RT-hybrid interface that undergoes confor-
mational changes between two catalytic states. Structural
features of the nucleoprotein complex, including drug
resistance mutations, have been verified by site-directed
mutagenesis, and will be presented.
Although the single-subunit RT of Moloney murine
leukemia virus (Mo-MLV) has been extensively charac-
terized biochemically, structural information is lacking
that describes the substrate binding mechanism for this
RT species. We also present data on the first crystal
structure of a complex between an RNA/DNA hybrid
and the 72 kDa single-subunit RT from the related
xenotropic murine leukemia virus-related virus (XMRV)
[2]. A comparison of this structure with its HIV-1 coun-
terpart shows that substrate binding around the DNA
polymerase active site is conserved but differs between
the two enzymes in their thumb and connection subdo-
mains. Small-angle X-ray scattering (SAXS) was used to
model full-length XMRV RT, demonstrating its flexible
RNase H domain becomes ordered in the presence of
substrate, a key difference between monomeric and
dimeric RTs.
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